查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595247

儿科医疗市场：按类型、治疗药物、治疗类型 - 2025-2030 年全球预测

Pediatric Health Market by Type (Acute Illness, Chronic Illness), Therapeutics (Allergy & Immunology, Cardiology, Gastroenterology), Treatment Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年儿科医疗市场规模为1,060.4亿美元，预计2024年将达1,136.3亿美元，复合年增长率为8.00%，2030年将达1818.3亿美元。

儿科医疗保健市场被定义为专注于婴幼儿、儿童和青少年的医疗保健、健康和整体健康的行业，涵盖从诊断到治疗解决方案的广泛服务。该市场的驱动因素是确保儿童从出生到青春期的健康，从而预防和管理急性和慢性疾病，促进全面发展。其应用范围涵盖医院、小儿科诊所、药房和居家照护服务，最终用途扩展到公共医疗机构、私人医疗保健提供者和私人家庭护理。关键的成长要素包括基于人工智慧的诊断等技术进步、对儿科医疗问题的认识提高以及医疗保健支出的增加。儿童疾病盛行率的增加、人口规模的迅速扩大以及儿科医疗设备的创新也对这一增长做出了重大贡献。透过投资远端医疗以远端存取儿科医疗保健并开发针对个人基因谱的个人化医疗，充分利用潜在的商机。限制包括监管障碍、高昂的研发成本以及需要严格的临床试验，这可能会延迟产品的上市。此外，市场碎片化和对新技术的抵制等挑战也可能阻碍成长。创新领域包括开发用于即时健康监测的可穿戴技术以及增强电子健康记录（EHR）系统以实现无缝资料整合。寻求发展的公司应该探索与高科技公司的合作，开发人工智慧驱动的医疗解决方案，并利用巨量资料分析来建立预测医疗模型。在整体预防医学和个人化医学趋势的背景下，市场正在发生重大变化。透过应对当前的监管复杂性、在药物开发中利用生物资讯学以及培养跨行业伙伴关係关係，公司可以占据重要的市场占有率并推动儿科医疗保健的未来成长。

主要市场统计
基准年[2023] 1060.4亿美元
预测年份 [2024] 1136.3亿美元
预测年份 [2030] 1818.3亿美元
复合年增长率（%） 8.00%

市场动态：揭示快速发展的儿科医疗保健市场的关键市场洞察

供需的动态交互作用正在改变儿科医疗保健市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 患有常见儿童疾病的儿童数量不断增加
    • 政府针对儿童免疫计画的倡议
    • 儿童慢性病负担增加
  • 市场限制因素
    • 新生儿及罕见儿科疾病药物开发有限
  • 市场机会
    • 重视罕见疾病新药和治疗方法的研发与引进
    • 增加儿科药物和疫苗开发的投资和可用性
  • 市场挑战
    • 与药物相关的併发症

波特五力：驾驭儿科医疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解儿科医疗保健市场的外部影响

外部宏观环境因素在塑造儿科医疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解儿科医疗市场的竞争状况

对儿科医疗保健市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵儿科医疗市场供应商的绩效评估

FPNV定位矩阵是评估儿科医疗保健市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划儿科医疗保健市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，儿科医疗保健市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 大量儿童患有常见儿童疾病
      • 政府关于儿童免疫计划的倡议
      • 儿童慢性病负担日益加重
    • 抑制因素
      • 新生儿及儿童罕见疾病药物开发有限
    • 机会
      • 专注于罕见疾病新药、新治疗方法的研发与引进
      • 增加对儿科药品和疫苗研发和供应的投资
    • 任务
      • 药物相关併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章儿科医疗市场：依类型

  • 急性疾病
  • 慢性病

第七章 儿科医疗市场治疗

  • 过敏和免疫学
  • 心臟病学
  • 胃肠病学
    • 制酸剂
    • 止泻
    • 泻药
  • 感染疾病

第八章 依治疗类型分類的儿科医疗市场

  • 症状治疗
    • 药品
    • 疫苗
  • 自然的

第九章美洲儿科医疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区儿科医疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲儿科医疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Allucent
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • GP Pharm, SA
  • Henin Lukinz Pvt. Ltd.
  • Janssen Global Services LLC
  • Medexus Pharmaceuticals, Inc.
  • Novartis AG
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Procter & Gamble Company
  • Proveca Ltd.
  • Sanofi SA
Product Code: MRR-62667ADF93FE

The Pediatric Health Market was valued at USD 106.04 billion in 2023, expected to reach USD 113.63 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 181.83 billion by 2030.

The pediatric health market, defined as the sector focusing on medical care, wellness, and the overall health of infants, children, and adolescents, encompasses a range of services from diagnostics to treatment solutions. This market is driven by the necessity to ensure child health from birth through adolescence, thereby preventing and managing acute and chronic conditions to foster holistic development. Its application spans hospitals, pediatric clinics, pharmacies, and home care services, with end-use extending into public health organizations, private healthcare providers, and individual family care. Key growth factors include technological advancements like AI-driven diagnostics, growing awareness of pediatric health issues, and increased healthcare expenditure. The increasing prevalence of pediatric diseases, the booming population size, and innovation in pediatric medical devices also contribute significantly to this growth. Potential opportunities can be harnessed by investing in telemedicine for remote child healthcare access and developing personalized medicine to cater to individual genetic profiles. Limitations include regulatory hurdles, high R&D costs, and the need for rigorous clinical trials which can delay product launches. Additionally, challenging factors such as market fragmentation and resistance to new technologies could hinder growth potential. Innovation areas include development in wearable technology for real-time health monitoring and enhancing electronic health record (EHR) systems for seamless data integration. Businesses keen on growth should explore collaborations with tech firms to create AI-powered medical solutions and leverage big data analysis for predictive health care models. The market is profoundly dynamic, with a trend towards holistic, preventive, and personalized care. By addressing current regulatory complexities, utilizing bioinformatics for drug development, and fostering cross-industry partnerships, firms can capture significant market share and drive future growth in pediatric healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 106.04 billion
Estimated Year [2024] USD 113.63 billion
Forecast Year [2030] USD 181.83 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Health Market

The Pediatric Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant pediatric population suffering from common childhood Illnesses
    • Government initiatives for pediatric immunization programs
    • Rising burden of chronic pediatric diseases
  • Market Restraints
    • Limited development of drugs targeting neonates and rare pediatric diseases
  • Market Opportunities
    • Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
    • Increasing investment in pediatric drug & vaccine development and its availability
  • Market Challenges
    • Complications associated with drugs

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Health Market

A detailed market share analysis in the Pediatric Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Health Market

A strategic analysis of the Pediatric Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Health Market, highlighting leading vendors and their innovative profiles. These include Allucent, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Gilead Sciences, Inc., GlaxoSmithKline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Janssen Global Services LLC, Medexus Pharmaceuticals, Inc., Novartis AG, ORPHELIA Pharma, Pfizer Inc., Procter & Gamble Company, Proveca Ltd., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Pediatric Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Acute Illness and Chronic Illness.
  • Based on Therapeutics, market is studied across Allergy & Immunology, Cardiology, Gastroenterology, and Infectious Disease. The Gastroenterology is further studied across Antacids, Antidiarrheal, and Laxatives.
  • Based on Treatment Type, market is studied across Allopathic and Natural. The Allopathic is further studied across Drugs and Vaccines.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant pediatric population suffering from common childhood Illnesses
      • 5.1.1.2. Government initiatives for pediatric immunization programs
      • 5.1.1.3. Rising burden of chronic pediatric diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limited development of drugs targeting neonates and rare pediatric diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
      • 5.1.3.2. Increasing investment in pediatric drug & vaccine development and its availability
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Health Market, by Type

  • 6.1. Introduction
  • 6.2. Acute Illness
  • 6.3. Chronic Illness

7. Pediatric Health Market, by Therapeutics

  • 7.1. Introduction
  • 7.2. Allergy & Immunology
  • 7.3. Cardiology
  • 7.4. Gastroenterology
    • 7.4.1. Antacids
    • 7.4.2. Antidiarrheal
    • 7.4.3. Laxatives
  • 7.5. Infectious Disease

8. Pediatric Health Market, by Treatment Type

  • 8.1. Introduction
  • 8.2. Allopathic
    • 8.2.1. Drugs
    • 8.2.2. Vaccines
  • 8.3. Natural

9. Americas Pediatric Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pediatric Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pediatric Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allucent
  • 2. AstraZeneca PLC
  • 3. Boehringer Ingelheim International GmbH
  • 4. Gilead Sciences, Inc.
  • 5. GlaxoSmithKline PLC
  • 6. GP Pharm, S.A.
  • 7. Henin Lukinz Pvt. Ltd.
  • 8. Janssen Global Services LLC
  • 9. Medexus Pharmaceuticals, Inc.
  • 10. Novartis AG
  • 11. ORPHELIA Pharma
  • 12. Pfizer Inc.
  • 13. Procter & Gamble Company
  • 14. Proveca Ltd.
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC HEALTH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC HEALTH MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ACUTE ILLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHRONIC ILLNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLERGY & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTIDIARRHEAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
  • TABLE 234. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023